Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Viruses ; 14(8)2022 08 19.
Artículo en Inglés | MEDLINE | ID: mdl-36016443

RESUMEN

Umbraviruses are a special class of plant viruses that do not encode any viral structural proteins. Here, a novel umbravirus that has been tentatively named Paederia scandens chlorosis yellow virus (PSCYV) was discovered through RNA-seq in Paederia scandens plants showing leaf chlorosis and yellowing symptoms. The PSCYV genome is a 4301 nt positive-sense, single strand RNA that contains four open reading frames (ORFs), i.e., ORF1-4, that encode P1-P4 proteins, respectively. Together, ORF1 and ORF2 are predicted to encode an additional protein, RdRp, through a -1 frameshift mechanism. The P3 protein encoded by ORF3 was predicted to be the viral long-distance movement protein. P4 was determined to function as the viral cell-to-cell movement protein (MP) and transcriptional gene silencing (TGS) suppressor. Both P1 and RdRp function as weak post-transcriptional gene silencing (PTGS) suppressors of PSCYV. The PVX-expression system indicated that all viral proteins may be symptom determinants of PSCYV. Phylogenetic analysis indicated that PSCYV is evolutionarily related to members of the genus Umbravirus in the family Tombusviridae. Furthermore, a cDNA infectious clone of PSCYV was successfully constructed and used to prove that PSCYV can infect both Paederia scandens and Nicotiana benthamiana plants through mechanical inoculation, causing leaf chlorosis and yellowing symptoms. These findings have broadened our understanding of umbraviruses and their host range.


Asunto(s)
Anemia Hipocrómica , Tombusviridae , Anemia Hipocrómica/genética , Genoma Viral , Sistemas de Lectura Abierta , Filogenia , Enfermedades de las Plantas , Hojas de la Planta , ARN Viral/genética , ARN Polimerasa Dependiente del ARN , Tombusviridae/genética , Proteínas Virales/genética
2.
Acta Trop ; 200: 105171, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31521623

RESUMEN

The ability of Aedes albopictus Skuse to transmit several pathogens to humans makes it a very important mosquito with public health significance. Ecofriendly products as alternatives to synthetic chemicals for the control of mosquito vectors are needed. Therefore, the larvicidal and repellent effects of two nontoxic chemicals, butyl anthranilate (BA) and ethyl anthranilate (EA), at different concentrations were compared in A. albopictus. The repellency persistence of BA and three commercial mosquito repellent products (Liushen repellent spray, DKB Korean, Raid repellent spray) against A. albopictus was compared. The results showed that 0.1% concentrations of BA and EA solutions were highly toxic to A. albopictus larvae, and the mortality rate was >90% after 4 h of treatment. We found that BA was more repellent than EA, and at 0.1% BA and 1% EA, and the repellency rates were 53.62% and 38.47%, respectively. Overall, 5% BA presented a significantly longer repellency time than the three commercial repellent products against female A. albopictus. These results indicate that BA has significant larvicidal and repellent effects and can be exploited further for the development of ecofriendly alternatives to existing toxic chemicals currently used for mosquito control.


Asunto(s)
Aedes/efectos de los fármacos , Repelentes de Insectos/farmacología , Larva/efectos de los fármacos , Control de Mosquitos/métodos , Mosquitos Vectores/efectos de los fármacos , ortoaminobenzoatos/farmacología , Animales , Femenino , Humanos
3.
Neurochem Int ; 115: 80-84, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29458076

RESUMEN

Spinal cord injury (SCI) disrupts the spinal cord and results in the loss of sensory and motor function below the lesion site. The treatment of SCI became a challenge because the injured neurons fail to axon regenerate and repair after injury. Promoting axonal regeneration plays a key role in the treatment strategies for SCI. It would meet the goal of reconstruction the injured spinal cord and improving the functional recovery. Bone marrow mesenchymal stem cells (BMSCs) are attractive therapeutic potential cell sources for SCI, and it could rebuild the injured spinal cord through neuroprotection, neural regeneration and remyelinating. Evidence has demonstrated that BMSCs play important roles in mediating axon regeneration, and glial scar formation after SCI in animal experiments and some clinical trials. We reviewed the role of BMSCs in regulating axon regeneration and glial scar formation after SCI. BMSCs based therapies may provide a therapeutic potential for the injured spinal cord by promoting axonal regeneration and repair.


Asunto(s)
Axones/patología , Células de la Médula Ósea/citología , Células Madre Mesenquimatosas/citología , Regeneración Nerviosa/fisiología , Traumatismos de la Médula Espinal/terapia , Animales , Trasplante de Células Madre Mesenquimatosas/métodos , Recuperación de la Función/fisiología
4.
Int Ophthalmol ; 38(5): 2053-2060, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28852897

RESUMEN

PURPOSE: In this study, we elucidated the effects of berberine, a major alkaloid component contained in medicinal herbs, such as Phellodendri Cortex and Coptidis Rhizoma, on expression of monocyte chemotactic protein-1 (MCP-1) and interleukin-8 (IL-8) in a human retinal pigment epithelial cell line (ARPE-19) caused by lipopolysaccharide (LPS) stimulation. METHODS: ARPE-19 cells were cultured to confluence. Berberine and LPS were added to the medium. MCP-1 and IL-8 mRNA were measured by real-time polymerase chain reaction. MCP-1 and IL-8 protein concentrations in the media were measured using enzyme-linked immunosorbent assay. RESULTS: After stimulation with LPS, MCP-1 and IL-8 mRNA in ARPE-19 cells reached maximum levels at 3 h, and MCP-1 and IL-8 protein in the culture media reached maximum levels at 24 h. Berberine dose-dependently inhibited MCP-1 and IL-8 mRNA expression of the cells and protein levels in the media stimulated with LPS. CONCLUSIONS: These findings indicate that berberine inhibited the expression of MCP-1 and IL-8 induced by LPS.


Asunto(s)
Berberina/farmacología , Quimiocina CCL2/genética , Regulación de la Expresión Génica/efectos de los fármacos , Interleucina-8/genética , Degeneración Macular/genética , Epitelio Pigmentado Ocular/metabolismo , ARN/genética , Células Cultivadas , Quimiocina CCL2/biosíntesis , Ensayo de Inmunoadsorción Enzimática , Humanos , Interleucina-8/biosíntesis , Lipopolisacáridos/farmacología , Degeneración Macular/metabolismo , Degeneración Macular/patología , Epitelio Pigmentado Ocular/efectos de los fármacos , Epitelio Pigmentado Ocular/patología
5.
Front Cell Neurosci ; 9: 5, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25674053

RESUMEN

Interferon-alpha (IFN-α) is a proinflammatory cytokine that is widely used for the treatment of chronic viral hepatitis and malignancy, because of its immune-activating, antiviral, and antiproliferative properties. However, long-term IFN-α treatment frequently causes depression, which limits its clinical utility. The precise molecular and cellular mechanisms of IFN-α-induced depression are not currently understood. Neural stem cells (NSCs) in the hippocampus continuously generate new neurons, and some evidence suggests that decreased neurogenesis plays a role in the neuropathology of depression. We previously reported that IFN-α treatment suppressed hippocampal neurogenesis and induced depression-like behaviors via its receptors in the brain in adult mice. However, it is unclear how systemic IFN-α administration induces IFN-α signaling in the hippocampus. In this study, we analyzed the role of microglia, immune cells in the brain, in mediating the IFN-α-induced neurogenic defects and depressive behaviors. In vitro studies demonstrated that IFN-α treatment induced the secretion of endogenous IFN-α from microglia, which suppressed NSC proliferation. In vivo treatment of adult mice with IFN-α for 5 weeks increased the production of proinflammatory cytokines, including IFN-α, and reduced neurogenesis in the hippocampus. Both effects were prevented by simultaneous treatment with minocycline, an inhibitor of microglial activation. Furthermore, minocycline treatment significantly suppressed IFN-α-induced depressive behaviors in mice. These results suggest that microglial activation plays a critical role in the development of IFN-α-induced depression, and that minocycline is a promising drug for the treatment of IFN-α-induced depression in patients, especially those who are low responders to conventional antidepressant treatments.

6.
PLoS One ; 10(1): e112281, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25559358

RESUMEN

OBJECTIVE: Objective: Although serum C-peptide has increasingly received attention as a new and important risk factor for cardiovascular disease (CVD), the potential mechanisms remain unclear. This study aimed to investigate the association between serum C-peptide as a risk factor for CVD and high-density lipoprotein cholesterol (HDL-C) levels. METHODS: The present study included 13,185 participants aged ≥20 years. Serum C-peptide and HDL-C levels were measured according to a standard protocol. Stratified analysis of covariance was used to compare serum HDL-C levels between different quartiles of serum C-peptide levels. Logistic regression analysis was used to determine the association between serum C-peptide and HDL-C levels. Cox proportional hazard regression analysis was conducted to determine the hazard ratio of serum HDL-C for CVD-related mortality. RESULTS: The results of the ANCOVA analysis showed a significant linear trend between the mean serum HDL-C level and the different quartiles of serum C-peptide. Compared to the first quartile (25th percentile), the second, third, and fourth quartiles had gradual reduction in serum HDL-C levels. Logistic regression analyses showed a strong negative association between serum C-peptide levels and HDL-C levels; the p value for the linear trend was <0.001. In men, compared with the lowest quartile of the serum C-peptide level, the relative risk was 1.75, 2.79, and 3.07 for the upper three quartiles of the serum C-peptide level. The relative risk was 1.60, 2.61, and 3.67 for women. The results of the survival analysis showed that serum HDL-C levels were negatively associated with CVD-related death in both men and women. CONCLUSION: Serum C-peptide as a risk factor for CVD was significantly and negatively associated with serum HDL-C levels in individuals without diabetes. These findings suggest that serum C-peptide levels association with CVD death can be caused, at least in part, by the low serum HDL-C level.


Asunto(s)
Péptido C/sangre , Enfermedades Cardiovasculares/sangre , HDL-Colesterol/sangre , Medición de Riesgo/métodos , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Enfermedades Cardiovasculares/diagnóstico , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Modelos de Riesgos Proporcionales , Medición de Riesgo/estadística & datos numéricos , Factores de Riesgo , Análisis de Supervivencia , Adulto Joven
7.
Stem Cell Reports ; 3(1): 73-84, 2014 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-25068123

RESUMEN

New neurons generated by the neural stem cells (NSCs) in the adult hippocampus play an important role in emotional regulation and respond to the action of antidepressants. Depression is a common and serious side effect of interferon-α (IFN-α), which limits its use as an antiviral and antitumor drug. However, the mechanism(s) underlying IFN-induced depression are largely unknown. Using a comprehensive battery of behavioral tests, we found that mice subjected to IFN-α treatment exhibited a depression-like phenotype. IFN-α directly suppressed NSC proliferation, resulting in the reduced generation of new neurons. Brain-specific mouse knockout of the IFN-α receptor prevented IFN-α-induced depressive behavioral phenotypes and the inhibition of neurogenesis, suggesting that IFN-α suppresses hippocampal neurogenesis and induces depression via its receptor in the brain. These findings provide insight for understanding the neuropathology underlying IFN-α-induced depression and for developing new strategies for the prevention and treatment of IFN-α-induced depressive effects.


Asunto(s)
Depresión/inducido químicamente , Interferón-alfa/efectos adversos , Células-Madre Neurales/patología , Animales , Proliferación Celular/efectos de los fármacos , Proliferación Celular/fisiología , Células Cultivadas , Depresión/metabolismo , Depresión/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Células-Madre Neurales/efectos de los fármacos
8.
Oxid Med Cell Longev ; 2013: 367206, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24454980

RESUMEN

Oxidative stress is crucially involved in the pathogenesis of neurological diseases such as stroke and degenerative diseases. We previously demonstrated that platelet-derived growth factors (PDGFs) protected neurons from H2O2-induced oxidative stress and indicated the involvement of PI3K-Akt and MAP kinases as an underlying mechanism. Ca(2+) overload has been shown to mediate the neurotoxic effects of oxidative stress and excitotoxicity. We examined the effects of PDGFs on H2O2-induced Ca(2+) overload in primary cultured neurons to further clarify their neuroprotective mechanism. H2O2-induced Ca(2+) overload in neurons in a dose-dependent manner, while pretreating neurons with PDGF-BB for 24 hours largely suppressed it. In a comparative study, the suppressive effects of PDGF-BB were more potent than those of PDGF-AA. We then evaluated calpain activation, which was induced by Ca(2+) overload and mediated both apoptotic and nonapoptotic cell death. H2O2-induced calpain activation in neurons in a dose-dependent manner. Pretreatment of PDGF-BB completely blocked H2O2-induced calpain activation. To the best of our knowledge, the present study is the first to demonstrate the mechanism underlying the neuroprotective effects of PDGF against oxidative stress via the suppression of Ca(2+) overload and inactivation of calpain and suggests that PDGF-BB may be a potential therapeutic target of neurological diseases.


Asunto(s)
Calcio/metabolismo , Calpaína/metabolismo , Neuronas/enzimología , Neuronas/patología , Estrés Oxidativo/efectos de los fármacos , Factor de Crecimiento Derivado de Plaquetas/farmacología , Proteínas Proto-Oncogénicas c-sis/farmacología , Animales , Becaplermina , Activación Enzimática/efectos de los fármacos , Humanos , Peróxido de Hidrógeno/farmacología , Espacio Intracelular/metabolismo , Iones , Ratones , Ratones Endogámicos C57BL , Neuronas/efectos de los fármacos
9.
J Neurosci Res ; 88(6): 1273-84, 2010 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-19998489

RESUMEN

The neuroprotective effects of platelet-derived growth factor (PDGF) and the major signaling pathways involved in these were examined using primary cultured mouse cortical neurons subjected to H(2)O(2)-induced oxidative stress. The specific function of the PDGF beta-receptor (PDGFR-beta) was examined by the selective deletion of the corresponding gene using the Cre-loxP system in vitro. In wild-type neurons, PDGF-BB enhanced the survival of these neurons and suppressed H(2)O(2)-induced caspase-3 activation. The prosurvival effect of PDGF-AA was less than that of PDGF-BB. PDGF-BB highly activated Akt, extracellular signal-regulated kinase (ERK), c-jun amino-terminal kinase (JNK) and p38. PDGF-AA activated these molecules at lesser extent than PDGF-BB. In particular, PDGF-AA induced activation of Akt was at very low level. The neuroprotective effects of PDGF-BB were antagonized by inhibitors of phosphatidylinositol 3-kinase (PI3-K), mitogen-activated protein kinase kinase (MEK), JNK and p38. The PDGFR-beta-depleted neurons showed increased vulnerability to oxidative stress, and less responsiveness to PDGF-BB-induced cytoprotection and signal activation, in which Akt activation was most strongly suppressed. After all, these results demonstrated the neuroprotective effects of PDGF and the signaling pathways involved against oxidative stress. The effects of PDGF-BB were more potent than those of PDGF-AA. This might be due to the activation and additive effects of two PDGFRs after PDGF-BB stimulation. Furthermore, the PI3-K/Akt pathway that was deduced to be preferentially activated by PDGFR-beta may explain the potent effects of PDGF-BB.


Asunto(s)
Corteza Cerebral/fisiología , Neuronas/fisiología , Estrés Oxidativo/fisiología , Factor de Crecimiento Derivado de Plaquetas/metabolismo , Receptor beta de Factor de Crecimiento Derivado de Plaquetas/metabolismo , Animales , Apoptosis/fisiología , Becaplermina , Caspasa 3/metabolismo , Supervivencia Celular/fisiología , Células Cultivadas , Corteza Cerebral/enzimología , Humanos , Peróxido de Hidrógeno/metabolismo , Peróxido de Hidrógeno/toxicidad , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Neuronas/enzimología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Proto-Oncogénicas c-sis , Receptor beta de Factor de Crecimiento Derivado de Plaquetas/deficiencia , Receptor beta de Factor de Crecimiento Derivado de Plaquetas/genética , Proteínas Recombinantes/metabolismo , Transducción de Señal
10.
Jpn J Ophthalmol ; 51(1): 64-7, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17295145

RESUMEN

PURPOSE: To examine the effects of berberine, an alkaloid isolated from some medicinal herbs, on the disruption of the barrier function in a human retinal pigment epithelial cell line (ARPE-19) stimulated with interleukin-1beta (IL-1beta). METHODS: ARPE-19 cells were cultured to confluence. Berberine and IL-1beta were added to the medium. Barrier functions were evaluated by measuring transepithelial electrical resistance (TER) and the permeability to horseradish peroxidase (HRP) and sodium fluorescein (SF). RESULTS: Berberine dose-dependently inhibited decreased TER and increased the permeability to HRP and SF in the cells stimulated with IL-1beta. CONCLUSIONS: Berberine dose-dependently inhibited the disruption of the barrier function in the ARPE-19 cell line induced by IL-1beta.


Asunto(s)
Berberina/farmacología , Barrera Hematorretinal/fisiología , Epitelio Pigmentado Ocular/efectos de los fármacos , Transporte Biológico/efectos de los fármacos , Línea Celular , Permeabilidad de la Membrana Celular , Relación Dosis-Respuesta a Droga , Impedancia Eléctrica , Electrofisiología , Fluoresceína/metabolismo , Peroxidasa de Rábano Silvestre/metabolismo , Humanos , Interleucina-1beta/farmacología , Epitelio Pigmentado Ocular/metabolismo
11.
Ophthalmic Res ; 39(1): 32-9, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17164575

RESUMEN

PURPOSE: The aims of this study were to examine the in vivo effects of berberine, an alkaloid isolated from some medicinal herbs, on monocyte chemotactic protein-1 (MCP-1) and cytokine-induced neutrophil chemoattractant-1 (CINC-1) expression in rat lipopolysaccharide (LPS)-induced uveitis. METHODS: LPS was injected intraperitoneally. Berberine was orally administered. MCP-1 mRNA and CINC-1 mRNA were measured by semiquantitative reverse-transcription polymerase chain reaction and real-time polymerase chain reaction. MCP-1 and CINC-1 protein concentration in the aqueous humor were measured by enzyme-linked immunosorbent assay. Histopathologic study was performed in the anterior ocular segments. RESULTS: Berberine dose-dependently inhibited LPS-induced MCP-1 mRNA and CINC-1 mRNA expression of the iris-ciliary body. The alkaloid inhibited chemokines, protein and cell levels in the aqueous humor in rats stimulated with LPS. On histopathologic study, the inflammatory cell infiltration was diminished by the berberine treatment. CONCLUSIONS: These findings indicate that berberine dose-dependently inhibited the expression of MCP-1 and CINC-1 induced by LPS and diminished the anterior uveitis.


Asunto(s)
Berberina/uso terapéutico , Quimiocina CCL2/genética , Quimiocinas CXC/genética , Expresión Génica/efectos de los fármacos , ARN Mensajero/metabolismo , Uveítis Anterior/tratamiento farmacológico , Animales , Quimiocina CXCL1 , Cuerpo Ciliar/metabolismo , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Iris/metabolismo , Lipopolisacáridos/toxicidad , Masculino , Reacción en Cadena de la Polimerasa , Ratas , Ratas Wistar , Uveítis Anterior/inducido químicamente , Uveítis Anterior/metabolismo
12.
J Neurochem ; 98(2): 588-600, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16805849

RESUMEN

Platelet-derived growth factors (PDGFs) and PDGF receptors (PDGFRs) are widely expressed in the mammalian CNS, though their functional significance remains unclear. The corresponding null-knockout mutations are lethal. Here, we developed novel mutant mice in which the gene encoding the beta subunit of PDGFR (PDGFR-beta) was genetically deleted in CNS neurons to elucidate the role of PDGFR-beta, particularly in the post-natal stage. Our mutant mice reached adulthood without apparent anatomical defects. In the mutant brain, immunohistochemical analyses showed that PDGFR-beta detected in neurons and in the cells in the subventricular zone of the lateral ventricle in wild-type mice was depleted, but PDGFR-beta detected in blood vessels remained unaffected. The cerebral damage after cryogenic injury was severely exacerbated in the mutants compared with controls. Furthermore, TdT-mediated dUTP-biotin nick end labeling (TUNEL)-positive neuronal cell death and lesion formation in the cerebral hemisphere were extensively exacerbated in our mutant mice after direct injection of NMDA without altered NMDA receptor expression. Our results clearly demonstrate that PDGFR-beta expressed in neurons protects them from cryogenic injury and NMDA-induced excitotoxicity.


Asunto(s)
Química Encefálica/fisiología , Encéfalo/crecimiento & desarrollo , Neuronas/fisiología , Receptor beta de Factor de Crecimiento Derivado de Plaquetas/deficiencia , Receptor beta de Factor de Crecimiento Derivado de Plaquetas/genética , Animales , Western Blotting , Encéfalo/citología , Encéfalo/patología , Daño Encefálico Crónico/genética , Daño Encefálico Crónico/patología , Cartilla de ADN , Congelación , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Proteínas de Filamentos Intermediarios/genética , Ratones , Ratones Noqueados , Mutación , N-Metilaspartato/toxicidad , Proteínas del Tejido Nervioso/genética , Nestina , Neuronas/patología , Regiones Promotoras Genéticas/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
13.
Life Sci ; 79(10): 949-56, 2006 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-16797033

RESUMEN

We examined the effects of berberrubine, a protoberberine alkaloid, on interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) expression in a human retinal pigment epithelial cell line (ARPE-19) stimulated with interleukin-1beta (IL-1beta) or tumor necrosis factor alpha (TNF-alpha). ARPE-19 cells were cultured to confluence. Berberrubine and IL-1beta or TNF-alpha were added to the medium. IL-8 and MCP-1 protein concentrations were measured using enzyme-linked immunosorbent assay. IL-8 and MCP-1 mRNA were measured by real time polymerase chain reaction. Nuclear factor kappaB (NF-kappaB) translocation was examined by immunofluorescent staining/microscopy. Berberrubine dose-dependently inhibited IL-8 and MCP-1 protein levels in the media and mRNA expression of the cells stimulated with IL-1beta or TNF-alpha. Immunofluorescent staining/microscopy of NF-kappaB in the nucleus of unstimulated cells was faint (51+/-14 arbitrary units). Fluorescein was dense (215+/-42 or 170+/-24 arbitrary units, respectively) 30 min after stimulation with IL-1beta or TNF-alpha and was decreased to 62+/-18 or 47+/-16 arbitrary units, respectively, by berberrubine. Berberrubine dose-dependently inhibited IL-8 and MCP-1 expression and protein secretion induced by IL-1beta or TNF-alpha. Possibly, the effect on chemotactic factors may be via suppression of NF-kappaB translocation.


Asunto(s)
Berberina/análogos & derivados , Quimiocina CCL2/metabolismo , Interleucina-8/metabolismo , Epitelio Pigmentado Ocular/efectos de los fármacos , Epitelio Pigmentado Ocular/metabolismo , Berberina/farmacología , Línea Celular , Quimiocina CCL2/genética , Expresión Génica/efectos de los fármacos , Humanos , Inmunohistoquímica , Interleucina-1/farmacología , Interleucina-8/genética , Estructura Molecular , Epitelio Pigmentado Ocular/citología , Transporte de Proteínas/efectos de los fármacos , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Factor de Transcripción ReIA/metabolismo , Factor de Necrosis Tumoral alfa/farmacología
14.
Ophthalmic Res ; 38(3): 149-57, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16391493

RESUMEN

PURPOSE: The aims of this study were to examine the effects of berberine, an alkaloid isolated from some medicinal herbs, on interleukin 8 (IL-8) and monocyte chemotactic protein 1 (MCP-1) expression in a human retinal pigment epithelial cell line (ARPE-19) stimulated with interleukin 1beta (IL-1beta) or tumor necrosis factor alpha (TNF-alpha). METHODS: ARPE-19 cells were cultured to confluence. Berberine and IL-1beta or TNF-alpha were added to the medium. IL-8 mRNA and MCP-1 mRNA were measured by semiquantitative reverse-transcription polymerase chain reaction and real-time polymerase chain reaction. IL-8 and MCP-1 protein concentrations in the media were measured using enzyme-linked immunosorbent assay. RESULTS: Berberine dose-dependently inhibited IL-8 mRNA and MCP-1 mRNA expression of the cells and protein levels in the media stimulated with IL-1beta or TNF-alpha. CONCLUSION: These findings indicate that berberine dose-dependently inhibited the expression of IL-8 and MCP-1 induced by IL-1beta or TNF-alpha.


Asunto(s)
Berberina/farmacología , Quimiocina CCL2/genética , Interleucina-8/genética , Epitelio Pigmentado Ocular/efectos de los fármacos , Línea Celular , Quimiocina CCL2/metabolismo , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Expresión Génica/efectos de los fármacos , Humanos , Interleucina-1/farmacología , Interleucina-8/metabolismo , Epitelio Pigmentado Ocular/metabolismo , ARN/aislamiento & purificación , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA